齐默尔曼-麦克林-福斯特假说：25年后
The Zimmerman-McLean-Foster hypothesis: 25 years later.
作者信息
Singh A D, Rennie I G, Kivela T, Seregard S, Grossniklaus H
机构信息
Department of Ophthalmic Oncology, Cole Eye Institute (i3-129), Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
出版信息
Br J Ophthalmol. 2004 Jul;88(7):962-7. doi: 10.1136/bjo.2003.029058.
Abstract
It is now 25 years since the publication of the landmark article by Zimmerman, McLean, and Foster, in which they cast doubts on the benefit of enucleation, which was the prevailing management of choroidal melanoma at that time. Over the past 25 years several advances have been made in the management of uveal melanoma. Research in the pathobiology of cancer metastasis in general and uveal melanoma in particular has also provided new insights. In this review, the Zimmerman-McLean-Foster hypothesis is explored in the light of current clinical, epidemiological, statistical, and experimental evidence.
摘要
自齐默尔曼、麦克莱恩和福斯特发表具有里程碑意义的文章至今已有25年，在那篇文章中，他们对眼球摘除术的益处提出了质疑，而眼球摘除术是当时脉络膜黑色素瘤的主流治疗方法。在过去的25年里，葡萄膜黑色素瘤的治疗取得了多项进展。对癌症转移，尤其是葡萄膜黑色素瘤的病理生物学研究也提供了新的见解。在这篇综述中，我们根据当前的临床、流行病学、统计学和实验证据探讨了齐默尔曼-麦克莱恩-福斯特假说。
相似文献
1
The Zimmerman-McLean-Foster hypothesis: 25 years later.
Br J Ophthalmol. 2004 Jul;88(7):962-7. doi: 10.1136/bjo.2003.029058.
2
The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
Am J Ophthalmol. 2004 Dec;138(6):936-51. doi: 10.1016/j.ajo.2004.07.006.
3
Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
Semin Ophthalmol. 2007 Jul-Sep;22(3):175-7. doi: 10.1080/08820530701501055.
4
Leptomeningeal Seeding in Choroidal Melanoma after Enucleation Surgery.
Korean J Ophthalmol. 2020 Apr;34(2):176-177. doi: 10.3341/kjo.2019.0101.
5
Legacy of the collaborative ocular melanoma study.
Arch Ophthalmol. 2007 Jul;125(7):966-8. doi: 10.1001/archopht.125.7.966.
6
A rationale for comparing radiation to enucleation in the management of choroidal melanoma.
Am J Ophthalmol. 1989 Oct 15;108(4):448-51. doi: 10.1016/s0002-9394(14)73317-3.
7
The investigators' perspective on the collaborative ocular melanoma study.
Arch Ophthalmol. 2007 Jul;125(7):968-71. doi: 10.1001/archopht.125.7.968.
8
Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma.
Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):251-7. doi: 10.1080/01658100701473275.
9
Internal eye wall resection for posterior uveal melanoma.
Jpn J Ophthalmol. 1993;37(3):287-92.
10
Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy.
Ophthalmologica. 2012;227(4):190-6. doi: 10.1159/000334401. Epub 2012 Jan 20.
引用本文的文献
1
Long Term Follow-Up Observation in Small Choroidal Melanocytic Tumors.
Cancers (Basel). 2024 Jul 23;16(15):2627. doi: 10.3390/cancers16152627.
2
Personalized treatment approaches in intraocular cancer.
Adv Ophthalmol Pract Res. 2024 Apr 13;4(3):112-119. doi: 10.1016/j.aopr.2024.03.005. eCollection 2024 Aug-Sep.
3
Expression of GNAQ, BAP1, SF3B1, and EIF1AX Proteins in the Aqueous Humor of Eyes Affected by Uveal Melanoma.
Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):15. doi: 10.1167/iovs.65.1.15.
4
Digital morphometry and cluster analysis identifies four types of melanocyte during uveal melanoma progression.
Commun Med (Lond). 2023 Apr 28;3(1):60. doi: 10.1038/s43856-023-00291-z.
5
Past, Present, and Future of Ocular Oncology in India.
Indian J Surg Oncol. 2022 Dec;13(Suppl 1):101-103. doi: 10.1007/s13193-022-01646-z. Epub 2022 Sep 14.
6
The Xiangya Ocular Tumor Bank: A Disease-Specific Biobank for Advancing Translational Research Into Ocular Tumors.
Front Med (Lausanne). 2022 Jan 27;8:774624. doi: 10.3389/fmed.2021.774624. eCollection 2021.
7
Mapping research trends of uveal melanoma: a bibliometric analysis.
Int Ophthalmol. 2022 Apr;42(4):1121-1131. doi: 10.1007/s10792-021-02098-0. Epub 2021 Nov 5.
8
Clinical determinants of long-term survival in metastatic uveal melanoma.
Cancer Immunol Immunother. 2022 Jun;71(6):1467-1477. doi: 10.1007/s00262-021-03090-4. Epub 2021 Oct 28.
9
Uveal melanoma diagnosis and current treatment options (Review).
Exp Ther Med. 2021 Dec;22(6):1428. doi: 10.3892/etm.2021.10863. Epub 2021 Oct 11.
10
Long-term results of visual function in posterior uveal melanoma patients treated with I125 episcleral brachytherapy in a Spanish referral Ocular Oncology Unit.
Arq Bras Oftalmol. 2021 Jul-Aug;84(4):330-338. doi: 10.5935/0004-2749.20210047.
本文引用的文献
1
Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model.
Mol Vis. 2004 Dec 23;10:987-95.
2
Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Ophthalmology. 2003 Nov;110(11):2223-34. doi: 10.1016/S0161-6420(03)00661-4.
3
Very long-term prognosis of patients with malignant uveal melanoma.
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9. doi: 10.1167/iovs.03-0538.
4
A biomathematical approach to clinical tumor growth.
Cancer. 1961 Nov-Dec;14:1272-94. doi: 10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h.
5
Uveal melanoma survival in Sweden from 1960 to 1998.
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3282-7. doi: 10.1167/iovs.03-0081.
6
Survival rates with uveal melanoma in the United States: 1973-1997.
Ophthalmology. 2003 May;110(5):962-5. doi: 10.1016/S0161-6420(03)00077-0.
7
HLA expression in uveal melanoma: there is no rule without some exception.
Hum Immunol. 2002 Jun;63(6):444-51. doi: 10.1016/s0198-8859(02)00389-0.
8
Invited commentary. Uveal melanoma: implications of tumor doubling time.
Ophthalmology. 2001 May;108(5):831-2. doi: 10.1016/s0161-6420(00)00609-6.
9
Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases.
Arch Ophthalmol. 2001 Dec;119(12):1805-9. doi: 10.1001/archopht.119.12.1805.
10
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.
Arch Ophthalmol. 2001 Jul;119(7):969-82. doi: 10.1001/archopht.119.7.969.
Zotero 插件